Investigating the effect of agomelatine and sertraline on anxiety and depressio

Phase 2

Recruiting

• Conditions: Condition 1: anxiety. Condition 2: depression.; Anxiety disorder due to known physiological condition; Other depressive episodes; F06.4; F32.8

• Registration Number: IRCT20230626058586N3
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 6 March 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 34

Inclusion Criteria

Confirmation of PNES diagnosis by neurologist and psychiatrist
Not suffering from mental disability and pregnancy
Age range between 18-65 years
Patient satisfaction

Exclusion Criteria

Patient's lack of consent to continue participating in the study
Confirmation of neurological disorder or other major disorders in addition to anxiety and depression during study
Not coming for a follow-up visit.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Depression. Timepoint: before the intervention and one month, two months and three months after the intervention. Method of measurement: Hamilton questionnaire.;Anxiety. Timepoint: before the intervention and one month, two months and three months after the intervention. Method of measurement: Hamilton questionnaire.

Secondary Outcome Measures

Name	Time	Method
Seizure attacks. Timepoint: before the intervention and one month, two months and three months after the intervention. Method of measurement: EEG.